Davis Thomas Andrew

Avg. Two Year Performance

36% Avg. Purchase Return
17% Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return4%9%4%(26%)36%
Purchase Success Rate1 of 22 of 22 of 20 of 22 of 2
Average Sale Return1%16%28%0%0%
Sale Success Rate1 of 22 of 22 of 20 of 20 of 2

AVANT Immunotherapeutics, I...

Drugs » Diagnostic Substances

Executive VP & CMO:

Holdings: 1.01K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

GenVec Inc.

Drugs » Biotechnology

Chief Medical Officer:

Holdings: 5.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Genocea Biosciences, Inc.

Drugs » Drugs - Generic

CHIEF MEDICAL OFFICER:

Holdings: 68.33K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--